MedPlus Health Services shares tumbled after the company reported a weaker-than-expected Q1FY27. Despite healthy 21.9% revenue growth to ₹1,880 crore, investors were disappointed by the profitability miss. Brokerage Nomura maintained its 'Buy' rating, highlighting MedPlus' long-term growth potential driven by its store expansion strategy.
MedPlus Health Services shares tumbled after the company reported a weaker-than-expected Q1FY27. Despite healthy 21.9% revenue growth to ₹1,880 crore, investors were disappointed by the profitability miss. Brokerage Nomura maintained its 'Buy' rating, highlighting MedPlus' long-term growth potential driven by its store expansion strategy.
<iframe src="https://hindustansphere.com/embed/cluster/0c34ff715402c5cd512c9fd45bd1c1003b8e1792" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="MedPlus Health shares tumble 16% after Q1 profit falls 21% YoY. Should you buy, sell or hold?"></iframe>
